Granahan Investment Management, LLC Biolife Solutions Inc Transaction History

Granahan Investment Management, LLC

  • $2.12 Billion
  • Q4 2024

A detailed history of Granahan Investment Management, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Granahan Investment Management, LLC holds 457,007 shares of BLFS stock, worth $12.2 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
457,007
Previous 658,634 30.61%
Holding current value
$12.2 Million
Previous $16.5 Million 28.04%
% of portfolio
0.56%
Previous 0.69%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$20.47 - $27.47 $4.13 Million - $5.54 Million
-201,627 Reduced 30.61%
457,007 $11.9 Million
Q3 2024

Nov 14, 2024
SELL
$19.19 - $26.52 $5.51 Million - $7.61 Million
-286,890 Reduced 30.34%
658,634 $16.5 Million
Q2 2024

Aug 14, 2024
SELL
$15.14 - $22.99 $2.03 Million - $3.09 Million
-134,321 Reduced 12.44%
945,524 $20.3 Million
Q1 2024

May 15, 2024
SELL
$15.35 - $18.82 $3.27 Million - $4.01 Million
-212,830 Reduced 16.46%
1,079,845 $20 Million
Q4 2023

Feb 14, 2024
BUY
$8.99 - $16.86 $2.16 Million - $4.05 Million
240,001 Added 22.8%
1,292,675 $21 Million
Q3 2023

Nov 14, 2023
BUY
$10.81 - $22.96 $1.17 Million - $2.49 Million
108,486 Added 11.49%
1,052,674 $14.5 Million
Q2 2023

Aug 14, 2023
BUY
$17.19 - $24.34 $1.6 Million - $2.26 Million
92,991 Added 10.92%
944,188 $20.9 Million
Q1 2023

May 15, 2023
BUY
$17.67 - $26.07 $95,700 - $141,195
5,416 Added 0.64%
851,197 $18.5 Million
Q4 2022

Feb 14, 2023
BUY
$16.95 - $25.07 $1.8 Million - $2.66 Million
105,908 Added 14.31%
845,781 $15.4 Million
Q3 2022

Nov 14, 2022
SELL
$14.64 - $26.7 $257,546 - $469,706
-17,592 Reduced 2.32%
739,873 $16.8 Million
Q2 2022

Aug 15, 2022
BUY
$10.54 - $24.2 $1.56 Million - $3.58 Million
147,861 Added 24.26%
757,465 $10.5 Million
Q1 2022

May 16, 2022
BUY
$20.81 - $37.29 $3.65 Million - $6.53 Million
175,172 Added 40.32%
609,604 $13.9 Million
Q4 2021

Feb 14, 2022
BUY
$32.99 - $58.55 $4.32 Million - $7.67 Million
130,989 Added 43.17%
434,432 $16.2 Million
Q3 2021

Nov 15, 2021
SELL
$42.03 - $60.5 $1.34 Million - $1.93 Million
-31,927 Reduced 9.52%
303,443 $12.8 Million
Q2 2021

Aug 16, 2021
BUY
$29.51 - $44.62 $578,838 - $875,221
19,615 Added 6.21%
335,370 $14.9 Million
Q1 2021

May 17, 2021
BUY
$32.95 - $44.24 $4.01 Million - $5.38 Million
121,592 Added 62.62%
315,755 $11.4 Million
Q4 2020

Feb 12, 2021
SELL
$27.5 - $45.75 $1.21 Million - $2.01 Million
-43,920 Reduced 18.45%
194,163 $7.75 Million
Q3 2020

Nov 12, 2020
SELL
$16.04 - $28.94 $373,715 - $674,273
-23,299 Reduced 8.91%
238,083 $6.89 Million
Q2 2020

Aug 14, 2020
SELL
$9.2 - $17.06 $120,786 - $223,980
-13,129 Reduced 4.78%
261,382 $4.27 Million
Q1 2020

May 12, 2020
SELL
$8.36 - $17.03 $25,514 - $51,975
-3,052 Reduced 1.1%
274,511 $2.61 Million
Q4 2019

Feb 14, 2020
BUY
$14.59 - $18.9 $109,104 - $141,334
7,478 Added 2.77%
277,563 $4.49 Million
Q3 2019

Nov 15, 2019
BUY
$15.7 - $20.98 $2.25 Million - $3.01 Million
143,595 Added 113.52%
270,085 $4.49 Million
Q2 2019

Aug 14, 2019
SELL
$15.2 - $19.42 $516 - $660
-34 Reduced 0.03%
126,490 $2.14 Million
Q1 2019

May 14, 2019
SELL
$10.9 - $21.26 $66,457 - $129,622
-6,097 Reduced 4.6%
126,524 $2.26 Million
Q4 2018

Feb 13, 2019
SELL
$9.5 - $17.17 $24,320 - $43,955
-2,560 Reduced 1.89%
132,621 $1.6 Million
Q3 2018

Nov 13, 2018
BUY
$14.99 - $25.48 $238,445 - $405,310
15,907 Added 13.34%
135,181 $2.37 Million
Q2 2018

Aug 15, 2018
BUY
$6.18 - $13.49 $737,113 - $1.61 Million
119,274 New
119,274 $1.36 Million

Others Institutions Holding BLFS

# of Institutions
188
Shares Held
47.1M
Call Options Held
4.3K
Put Options Held
4.7K
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.14B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email